George L. Sing
At a glance: George L. Sing is Director at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Nov 4, 2026, reported a sale of $1.2M. On file: 0 purchase lines ($0) and 9 sale lines ($20.4M).
Disclosed holdings: about $24.0M of REGN stock: 25,147 shares reported on their latest Form 4 (filed Nov 4, 2026), valued at the Nov 13, 2026 close of $955.47. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 1,22445,052 held (−3%) | $960.57 | $1.2M | -0.5% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 54044,512 held (−1%) | $961.85 | $519K | -0.7% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 2,52241,990 held (−6%) | $962.61 | $2.4M | -0.7% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 4,33837,652 held (−10%) | $963.47 | $4.2M | -0.8% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 2,67034,982 held (−7%) | $964.57 | $2.6M | -0.9% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 7,07327,909 held (−20%) | $965.38 | $6.8M | -1.0% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 1,52226,387 held (−5%) | $966.27 | $1.5M | -1.1% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 1,04025,347 held (−4%) | $967.07 | $1.0M | -1.2% |
| Nov 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 20025,147 held (−1%) | $970.18 | $194K | -1.5% |
Follow George L. Sing
Get one email when George L. Sing files a new purchase or sale. Free.
At most one email a day about George L. Sing, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.